Literature DB >> 15141306

Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking.

C E Creutz1, S L Snyder, T A Schulz.   

Abstract

In a survey of yeast genomic sequences encoding calcium- and phospholipid-binding C2 domains, three homologous genes were identified that encode proteins that each have three C2 domains and an apparent transmembrane domain near the N terminus. The name tricalbins is suggested for these proteins, corresponding to the open reading frames YOR086c (TCB1), YNL087w (TCB2), and YML072c (TCB3). An antiserum was raised against the C-terminal portion of tricalbin 2 and used on Western blots to demonstrate that the corresponding protein is expressed in yeast and appears as a high-molecular-weight band at 130 kDa with smaller fragments at 39 kDa and 46 kDa. A fusion protein consisting of full length tricalbin 2 fused to the green fluorescent protein was expressed in cells and found to traffic from the cell surface to intracellular vesicles near the vacuole. A two-hybrid interaction screen with the C-terminal portion of tricalbin 2 indicated that tricalbin 2 binds the C-terminal portions of tricalbins 1 and 3 suggesting that the tricalbins may form heterodimers in vivo. Tricalbin 2 also interacted with the activation domain of the pleiotropic drug resistance transcription factor Pdr1p. Combinatorial disruptions of the tricalbin genes revealed that tcb2 single mutants or tcb1, tcb3 double mutants have an altered vacuole morphology and are hypersensitive to cycloheximide. A screen for single-copy suppressors of the cycloheximide sensitivity of tricalbin mutants yielded RSP5, which encodes a C2-domain-containing, ubiquitin-conjugating ligase essential for receptor-mediated and fluid phase endocytosis. The results suggest that the tricalbins function as multimers in membrane-trafficking events and may provide insights into the roles of multi-C2-domain proteins, such as the synaptotagmins, in other organisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141306     DOI: 10.1007/s00018-004-4029-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  31 in total

Review 1.  Coronary microembolization.

Authors:  Andreas Skyschally; Kkirsten Leineweber; Petra Gres; Michael Haude; Raimund Erbel; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2006-09       Impact factor: 17.165

2.  Distal embolization during primary angioplasty: histopathologic features and predictability.

Authors:  Ugo Limbruno; Marco De Carlo; Sabina Pistolesi; Andrea Micheli; Anna Sonia Petronio; Tiziano Camacci; Gabriella Fontanini; Alberto Balbarini; Mario Mariani; Raffaele De Caterina
Journal:  Am Heart J       Date:  2005-07       Impact factor: 4.749

3.  Primary angioplasty in a high-volume tertiary center in Turkey: in-hospital clinical outcomes of 1625 patients.

Authors:  Cevat Kırma; Vecih Oduncu; Ali Cevat Tanalp; Ayhan Erkol; Cihan Dündar; Dicle Sırma; Kürşat Tigen; Selçuk Pala; Akın Izgi; Muhsin Türkmen; Hasan Sunar
Journal:  Turk Kardiyol Dern Ars       Date:  2011-06

Review 4.  A macro and micro view of coronary vascular insult in ischemic heart disease.

Authors:  M J Davies
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

5.  Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.

Authors:  Giampaolo Niccoli; Gaetano A Lanza; Cristina Spaziani; Luca Altamura; Enrico Romagnoli; Antonio Maria Leone; Beatrice Fusco; Carlo Trani; Francesco Burzotta; Mario A Mazzari; Rocco Mongiardo; Luigi M Biasucci; Antonio G Rebuzzi; Filippo Crea
Journal:  Int J Cardiol       Date:  2006-07-21       Impact factor: 4.164

6.  Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.

Authors:  Hon-Kan Yip; Mien-Cheng Chen; Hsueh-Wen Chang; Chi-Ling Hang; Yuan-Kai Hsieh; Chih-Yuan Fang; Chiung-Jen Wu
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

7.  Association of thrombotic and fibrinolytic factors with severity of culprit lesion in patients with acute coronary syndromes without ST elevation.

Authors:  Yasin Turker; Abdullah Dogan; Mehmet Ozaydin; Selcuk Kaya; Suleyman Onal; Mehmet Akkaya; Dogan Erdogan
Journal:  South Med J       Date:  2010-04       Impact factor: 0.954

8.  Quality of myocardial reperfusion according to ischemic time and infarcted territory.

Authors:  Fernando Cura; Mariano Albertal; Jorge Thierer; Alejandro Garcia Escudero; Alfonsina Candiello; Samir Jozami; Pablo Perez Baliño; Lucio T Padilla; Marcelo Trivi; Jorge A Belardi
Journal:  Coron Artery Dis       Date:  2011-03       Impact factor: 1.439

Review 9.  Pulmonary embolism and deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Henri Bounameaux
Journal:  Lancet       Date:  2012-04-10       Impact factor: 79.321

10.  Role of adenosine in hyperemic response of coronary blood flow in microembolization.

Authors:  M Hori; M Inoue; M Kitakaze; Y Koretsune; K Iwai; J Tamai; H Ito; A Kitabatake; T Sato; T Kamada
Journal:  Am J Physiol       Date:  1986-03
View more
  27 in total

1.  Arabidopsis synaptotagmin SYT1, a type I signal-anchor protein, requires tandem C2 domains for delivery to the plasma membrane.

Authors:  Tomokazu Yamazaki; Naoki Takata; Matsuo Uemura; Yukio Kawamura
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

2.  Extended Synaptotagmin Interaction with the Fibroblast Growth Factor Receptor Depends on Receptor Conformation, Not Catalytic Activity.

Authors:  Michel G Tremblay; Chelsea Herdman; François Guillou; Prakash K Mishra; Joëlle Baril; Sabrina Bellenfant; Tom Moss
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

3.  Evolutionary Engineering Improves Tolerance for Replacement Jet Fuels in Saccharomyces cerevisiae.

Authors:  Timothy C R Brennan; Thomas C Williams; Benjamin L Schulz; Robin W Palfreyman; Jens O Krömer; Lars K Nielsen
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

4.  PI(4,5)P(2)-dependent and Ca(2+)-regulated ER-PM interactions mediated by the extended synaptotagmins.

Authors:  Francesca Giordano; Yasunori Saheki; Olof Idevall-Hagren; Sara Francesca Colombo; Michelle Pirruccello; Ira Milosevic; Elena O Gracheva; Sviatoslav N Bagriantsev; Nica Borgese; Pietro De Camilli
Journal:  Cell       Date:  2013-06-20       Impact factor: 41.582

5.  Extended Synaptotagmin 1 Interacts with Herpes Simplex Virus 1 Glycoprotein M and Negatively Modulates Virus-Induced Membrane Fusion.

Authors:  Imane El Kasmi; Bita Khadivjam; Miki Lackman; Johanne Duron; Eric Bonneil; Pierre Thibault; Roger Lippé
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

6.  The plasma membrane proteins Prm1 and Fig1 ascertain fidelity of membrane fusion during yeast mating.

Authors:  Pablo S Aguilar; Alex Engel; Peter Walter
Journal:  Mol Biol Cell       Date:  2006-12-06       Impact factor: 4.138

7.  E-Syts, a family of membranous Ca2+-sensor proteins with multiple C2 domains.

Authors:  Sang-Won Min; Wen-Pin Chang; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

8.  Solution and membrane-bound conformations of the tandem C2A and C2B domains of synaptotagmin 1: Evidence for bilayer bridging.

Authors:  Dawn Z Herrick; Weiwei Kuo; Hao Huang; Charles D Schwieters; Jeffrey F Ellena; David S Cafiso
Journal:  J Mol Biol       Date:  2009-06-06       Impact factor: 5.469

9.  Extended synaptotagmins are Ca2+-dependent lipid transfer proteins at membrane contact sites.

Authors:  Haijia Yu; Yinghui Liu; Daniel R Gulbranson; Alex Paine; Shailendra S Rathore; Jingshi Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

10.  Postsynaptic regulation of synaptic plasticity by synaptotagmin 4 requires both C2 domains.

Authors:  Cynthia F Barber; Ramon A Jorquera; Jan E Melom; J Troy Littleton
Journal:  J Cell Biol       Date:  2009-10-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.